ISCD Strategic Plan 2026-28

Strengthening lives through excellence in musculoskeletal health assessment” – our new mission statement – is one of the many positive outcomes born from our strategic planning process. For the better part of last year, ISCD leadership, volunteers and staff shared their time, expertise and passion for the field of musculoskeletal health to formulate a three-year strategic plan for the society. We are excited to share the approved strategic plan priorities and goals.

Updated Mission Statement: Strengthening lives through excellence in musculoskeletal health assessment

Updated Vision Statement: Global leader in musculoskeletal health assessment

Strategic Priorities:

  • Achieve financial sustainability on a cash basis
  • Grow earned income through paid, on-demand courses
  • Expand Body Composition, as an extension of DXA
  • Grow international education and certification as external funding or individual self-funding allows
  • Evolve facility accreditation to ensure its long-term sustainability
  • Target fellows in radiology, endocrinology, and rheumatology for education and certification
  • Consider membership model changes that will strengthen member acquisition and retention
  • Restructure the Board to strengthen governance and engagement

Strategic Goals to achieve by the end of 2028:

  • ISCD will be net positive on a cash basis
  • ISCD will increase on-demand education net income to $10,000
  • Develop a DXA Basic Body Composition Analysis Certificate covering a Core Curriculum and advanced training in at least three specialty uses of DXA Body Composition
  • Offer ISCD Courses internationally through our Regional Panels without financial support from ISCD
  • Facility Accreditation program will attain net positive revenue
  • Course attendees and certified professionals in radiology, endocrinology and rheumatology increase by 15%
  • The Board structure transitions from committee/panel representation to one focused on governance, strategy, and revenue generation